GU CANCERS SYMPOSIUM 2024 ROUNDTABLE DISCUSSION: EV302
OR
Chair
Dr. Nazanin Fallah-Rad
Panelists
Dr. Sebastien Hotte
Dr. Maria Jiang
This program has been made possible through unrestricted support from EMD Serono & Ipsen
Studies/trials discussed:
- EV302 Study
- Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer
